IMVT
Immunovant, Inc.
+0.49 (+1.35%)36.87USD367K成交股數7.6B市值–本益比(近四季)305.3股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 8.9M | 3.6M | 4.1M | 3.5M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 143M | 98.9M | 114M | 101M | 93.7M | 94.5M | 97.3M | 75.5M | 48.3M | 48.0M | 50.6M | 51.8M |
| 銷售管理費用 | 17.7M | 15.4M | 17.5M | 26.0M | 20.2M | 19.8M | 18.5M | 18.8M | 13.2M | 13.8M | 15.4M | 12.4M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −153M+44% | −111M-0% | −127M+16% | −121M+38% | −106M+107% | −111M+89% | −109M+48% | −87.2M+47% | −51.4M | −58.7M | −73.9M | −59.4M |
| 淨利率 | – | – | – | – | – | – | – | – | -575.6% | -1,642.3% | -1,818.9% | -1,707.8% |
| 稀釋 EPS | -0.75+19% | -0.61-20% | -0.73-1% | -0.71+18% | -0.63+75% | -0.76+69% | -0.74+30% | -0.60+30% | -0.36 | -0.45 | -0.57 | -0.46 |
| 稀釋股數 | 206M | 182M | 174M | 171M | 152M | 147M | 146M | 146M | 145M | 131M | 131M | 123M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 798M | 995M | 522M | 599M | 714M | 375M | 473M | 560M | 691M | 270M | 330M | 377M |
| 應收帳款 | 697K | 1.6M | 2.0M | 1.9M | 2.1M | 2.2M | 1.9M | 2.4M | 1.0M | 1.4M | 823K | 700K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 852M | 1.1B | 583M | 661M | 776M | 421M | 516M | 590M | 711M | 292M | 351M | 406M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 117M | 66.3M | 63.3M | 52.9M | 68.8M | 68.3M | 66.7M | 45.0M | 32.1M | 40.3M | 51.4M | 43.3M |
| 股東權益 | 735M | 986M | 520M | 609M | 707M | 353M | 449M | 545M | 679M | 252M | 300M | 362M |
| 負債比 | 13.7% | 6.3% | 10.9% | 8.0% | 8.9% | 16.2% | 12.9% | 7.6% | 4.5% | 13.8% | 14.6% | 10.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −124M | – | – | −117M+54% | – | – | – | −76.2M | – | – | −47.4M | – |
| 資本支出 | – | – | – | 0.00 | – | – | – | 182K | – | – | 45K | – |
| 自由現金流 | – | – | – | −117M+54% | – | – | – | −76.4M | – | – | −47.4M | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | -1,166.4% | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −506M | –% | -2.77 | −407M |
| FY2025 | – | – | −414M | –% | -2.73 | −377M |
| FY2024 | 24.9M | +229.2% | −259M | -1,039.5% | -1.88 | −215M |
| FY2023 | 7.6M | – | −211M | -2,783.8% | -1.71 | −188M |
| FY2022 | 0.00 | – | −157M | –% | -1.43 | −106M |
| FY2021 | – | – | −107M | –% | -1.22 | −83.5M |
| FY2020 | – | – | −66.4M | –% | -1.54 | −53.4M |
| FY2019 | – | – | −28.6M | –% | -1.29 | −28.6M |